References
- Tegnell A, Aren C, Ohman L. Wound infections after car-diac surgery - a scoring system may improve early detection. Scand Cardiol J 2002; 36: 60–4.
- Losanoff J, Richman BW, Jones JW. Disruption and in-fection of median sternotomy: a comprehensive review. Eur J Cardiothorac Surg 2002; 21: 831–9
- Gummert JF, Barten MJ, Hans C, et al. Mediastinaitis and cardiac surgery - an updated risk factor analysis in 10,373 con-secutive adult patients. Thorac Cardiov Surg 2002; 50: 87–91
- Weed HG. Antimicrobial prophylaxis in the surgical pa-tient. Med Clin N Am 2003; 87: 59–75
- Martorell C, Engelman R, Corl A, et al. Surgical site infec-tions in cardiac surgery: an 11 year perspective. Am J Infect Control 2004; 32: 63–8
- Howden BP, Word PB, Charles PGP, et al. Treatment out-comes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 2004; 38: 521–8
- Sandoe JA, Kumar B, Stoddart B, Milton R, Dave J, Naar UR, Wilcox MH. Effect of extended perioperative prophylaxis on intravascular catheter colonization and infection in cardiothoracic surgery patients. J Antimicrob Chemother 2003; 52: 877–9
- Laurie A, Shroyer W, Coombs L, et al. The society of tho-racic surgeons: 30-day operative mortality risk models. Ann Tho-rac Surg 2003; 75: 1856-65
- Turnidge J. Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 1999; 12: S23–834
- Hurdle JG, 0' Neil MO, Chopra I. Anti-staphylococcal activity of indolmycin, a potential topical agent for control of staphylococcal infections. J Antimicrob Chemother 2004; 54: 549–52
- Kendall JB, Hart CA, Pennefather SH, Russell GN. In-fection control measures for adult cardiac surgery in UK-a survey of current practice. J Hosp Infect 2003; 54: 174–8
- Bergeron MG, Desaulnies D, Lessard C, et al. Concen-trations of fusidic acid, cloxacilin and cefamandole in sera and atrial appentages of patients undergoing cardiac surgery. An-timicrob Agents Chemother 1985; 27: 928–37
- Giamarellou H. Fourth generation cephalosporins in the antimicrobial chemotherapy of surgical infections. J Chemother 1999; 11: 486–93
- Giamarellos-Bourboulis EJ, Grecka P, Tsitsika A, Tympa-nidou C, Giamarellou H. In vitro activity of FK 037 (cefoselis), a novel 4th generation cephalosporin, compared to cefepime and cefpirome on nosocomial staphylococci and gram-negative iso-lates. Diagn Microbiol Infect Dis 2000; 36: 185–91.
- Sander S, Fritsche TR, Jones RN. Potency and spectrum trends for cefepime tested against 65.746 clinical bacterial iso-lates collected in North America medical centers: results from the SENTRY antimicrobial surveillance program (1998-2003). Diagn Microbiol Infect Dis 2005; 52: 265–73